New Treatment Strategies for Patients with Hypertension and Insulin Resistance
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference43 articles.
1. Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation;Alberti;Diabet Med,1998
2. Third report of the National Cholesterol Evaluation Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final report;Circulation,2002
3. The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French DESIR study;Balkau;Diabetes Metab,2003
4. A comparison of the prevalence of the metabolic syndrome using two proposed definitions;Ford;Diabetes Care,2003
5. Cardiovascular morbidity and mortality associated with the metabolic syndrome;Isomaa;Diabetes Care,2001
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Telmisartan versus metformin in downregulating myostatin gene expression and enhancing insulin sensitivity in the skeletal muscles of type 2 diabetic rat model;Frontiers in Pharmacology;2023-07-28
2. The Impact of Different Antihypertensive Drugs on Cardiovascular Risk in Isolated Systolic Hypertension with Type 2 Diabetes Patients;Journal of Clinical Medicine;2022-11-01
3. Association of diuretic use with increased risk for long-term post-transplantation diabetes mellitus in kidney transplant recipients;Nephrology Dialysis Transplantation;2022-01-29
4. The association of triglyceride and glucose index, and triglyceride to high‐density lipoprotein cholesterol ratio with prehypertension and hypertension in normoglycemic subjects: A large cross‐sectional population study;The Journal of Clinical Hypertension;2021-06-12
5. Anti-Diabetic Effect of Telmisartan Through its Partial PPARγ-Agonistic Activity;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2020-10
Anti-Diabetic Effect of Telmisartan Through its Partial PPARγ-Agonistic Activity
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3